drugset / Trial / NCT02749721
The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Phase 4
Completed
31 enrolled
Rush University Medical Center
ElMindA Ltd · collabTakeda Pharmaceuticals North America, Inc. · collab
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to explore patterns of Brain Network Activation (BNA) changes from baseline to endpoint on 1) efficacy of core symptoms of Major Depressive Disorder (MDD) and 2) improvement of cognitive dysfunction with acute treatment with flexible dose vortioxetine in adult outpatients with MDD and subjective complaints of cognitive dysfunction.
Timeline
- Start
- 2016-12
- Primary completion
- 2019-01-31
- Completion
- 2019-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vortioxetine | Unknown | — | — |